06-08-2024 02:53 PM | Source: Accord Fintech
Tata Elxsi gains on tying up with Skanray to advance surgical imaging, healthcare innovation

Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel

Tata Elxsi is currently trading at Rs. 6799.60, up by 27.50 points or 0.41% from its previous closing of Rs. 6772.10 on the BSE.

The scrip opened at Rs. 6755.15 and has touched a high and low of Rs. 6885.05 and Rs. 6755.15 respectively. So far 3399 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 9191.10 on 18-Dec-2023 and a 52 week low of Rs. 6406.60 on 04-Jun-2024.

Last one week high and low of the scrip stood at Rs. 7012.45 and Rs. 6619.75 respectively. The current market cap of the company is Rs. 42699.53 crore.

The promoters holding in the company stood at 43.92%, while Institutions and Non-Institutions held 19.92% and 36.17% respectively.

Tata Elxsi has been chosen as a strategic partner by Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, for advanced surgical imaging core technology and software platform development. This collaboration aims to revolutionise diagnosis and treatment by leveraging cutting-edge technology modules, making them predictable, accurate, and consistent.

Skanray is actively pursuing a long-term strategy to expand its portfolio by including new device families and modalities. This initiative aims to build a suite of reusable modules and components for medical devices, alongside the development of an advanced analytics cloud platform.

Tata Elxsi will lead a software platform-led approach to diagnostics that will support all imaging, critical care and surgical systems from the Skanray family, ensuring interoperability, compatibility and multimodal functionality. This platform will also incorporate the latest technologies and process efficiencies from AI and GenAI.

Combining Skanray's expertise in medical devices, core component technology, systems and applications with Tata Elxsi's domain experience in medical imaging, software platform development, digital capabilities in cloud, AI and analytics, and ready-to-use solution accelerators provides Skanray an opportunity to redefine the landscape of medical technology, with advanced, modular, and yet affordable diagnostics systems.

Tata Elxsi is a global design and technology Services Company and works with customers across industries such as automotive, broadcast, healthcare and telecom for product and software development.